BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7023773)

  • 1. Avascular bone necrosis in the renal transplant patient: a discriminant analysis of 144 cases.
    Elmstedt E
    Clin Orthop Relat Res; 1981; (158):149-57. PubMed ID: 7023773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avascular necrosis of bone following renal transplantation.
    Pierides AM; Simpson W; Stainsby D; Alvarez-ude F; Uldall PR
    Q J Med; 1975 Jul; 44(175):459-80. PubMed ID: 1101287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,25-dihydroxyvitamin D(3) therapy is protective for renal function and prevents hyperparathyroidism in renal allograft recipients.
    Uyar M; Sezer S; Arat Z; Elsurer R; Ozdemir FN; Haberal M
    Transplant Proc; 2006 Sep; 38(7):2069-73. PubMed ID: 16980002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteonecrosis of the hip in renal transplant recipients. Changes in functional status and magnetic resonance imaging findings over three years in three hundred five patients.
    Le Parc JM; André T; Helenon O; Benoit J; Paolaggi JB; Kreis H
    Rev Rhum Engl Ed; 1996 Jun; 63(6):413-20. PubMed ID: 8817751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperparathyroidism and avascular necrosis of bone after kidney transplantation. A retrospective study of 170 transplant recipients.
    De Graaf P; Van Hooff JP; Boekhout M; Achterberg J; Pauwels EK; Kalff MW
    Neth J Med; 1982; 25(7):230-6. PubMed ID: 6755282
    [No Abstract]   [Full Text] [Related]  

  • 6. Avascular necrosis of bone following renal transplantation.
    Naiker IP; Govender S; Naicker S; Dawood S; Haffejee AA; Seedat YK
    S Afr Med J; 1993 Sep; 83(9):646-9. PubMed ID: 8310355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avascular osteonecrosis after renal transplantation.
    Hedri H; Cherif M; Zouaghi K; Abderrahim E; Goucha R; Ben Hamida F; Ben Abdallah T; Elyounsi F; Ben Moussa F; Ben Maiz H; Kheder A
    Transplant Proc; 2007 May; 39(4):1036-8. PubMed ID: 17524885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation: a single center experience and a review.
    Tauchmanovà L; De Rosa G; Serio B; Fazioli F; Mainolfi C; Lombardi G; Colao A; Salvatore M; Rotoli B; Selleri C
    Cancer; 2003 May; 97(10):2453-61. PubMed ID: 12733144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicoepidemiologic study of posttransplant diabetes after living-donor renal transplant.
    Elmagd MM; Bakr MA; Metwally AH; Wahab AM
    Exp Clin Transplant; 2008 Mar; 6(1):42-7. PubMed ID: 18405244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum phosphate predicts mortality in renal transplant recipients.
    Connolly GM; Cunningham R; McNamee PT; Young IS; Maxwell AP
    Transplantation; 2009 Apr; 87(7):1040-4. PubMed ID: 19352125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous fractures in the renal graft recipient: a discriminant analysis of 144 cases.
    Elmstedt E
    Clin Orthop Relat Res; 1982; (162):195-201. PubMed ID: 7039910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid-related complications in the cyclosporine era.
    Fryer JP; Granger DK; Leventhal JR; Gillingham K; Najarian JS; Matas AJ
    Clin Transplant; 1994 Jun; 8(3 Pt 1):224-9. PubMed ID: 8061360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed graft function in renal transplant recipients: risk factors and impact on 1-year graft function: a single center analysis.
    Bronzatto EJ; da Silva Quadros KR; Santos RL; Alves-Filho G; Mazzali M
    Transplant Proc; 2009 Apr; 41(3):849-51. PubMed ID: 19376369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher initial tacrolimus blood levels and concentration-dose ratios in kidney transplant recipients who develop diabetes mellitus.
    Rodrigo E; de Cos MA; Fernández-Fresnedo G; Sánchez B; Ruiz JC; Piñera C; Palomar R; Cotorruelo JG; Gómez-Alamillo C; de Castro SS; de Francisco AL; Arias M
    Transplant Proc; 2005 Nov; 37(9):3819-20. PubMed ID: 16386549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.
    Rostaing L; Moreau-Gaudry X; Baron E; Cisterne JM; Monroziès-Bernadet P; Durand D
    Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Avascular bone necrosis after renal transplant].
    Feletti C; Docci D; Di Felice A; Bonomini V
    Minerva Nefrol; 1981; 28(1):89-91. PubMed ID: 7027088
    [No Abstract]   [Full Text] [Related]  

  • 17. Persistent hyperparathyroidism after kidney transplantation requiring parathyroidectomy.
    Evenepoel P; Kuypers D; Maes B; Messiaen T; Vanrenterghem Y
    Acta Otorhinolaryngol Belg; 2001; 55(2):177-86. PubMed ID: 11441477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
    Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
    Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Bergamo Kidney Transplant Program.
    Perico N; Cravedi P; Ruggenenti P; Gotti E; Rota G; Locatelli G; Gambara V; Perna A; Rota S; Remuzzi G
    Clin Transpl; 2005; ():85-100. PubMed ID: 17424727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.